Download - Anticoagulation theory 2_students_
![Page 1: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/1.jpg)
Anticoagulation Theory
To Bleed or Not to Bleed
![Page 2: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/2.jpg)
Coagulation Basics
• Ability of the body to control flow of blood following vascular injury is needed for survival
• Hemostasis: process of blood clotting and then the subsequent dissolution of the clot following repair of injured tissue
![Page 3: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/3.jpg)
Coagulation Basics
• Hemophilia: tendency to bleed
• Thrombophilia: tendency to clot
![Page 4: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/4.jpg)
Hemostasis
• Maintains circulating blood in fluid state
• Disrupts blood flow due to vessel injury to minimize anoxia and cellular death
• Facilitates maintenance of vascular integrity following injury
![Page 5: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/5.jpg)
Hemostasis
• Normally, there’s a balance between:
– Fibrin formation (thrombin mediated)
– Fibrin dissolution (plasmin mediated)
• Balance accomplished by interactions among:
– Blood vessels
– Platelets
– Coagulation proteins
– Fibrinolysis
![Page 6: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/6.jpg)
Hemostasis
• Complex interaction of cellular componentsand plasma proteins that once activated, result in clot formation to plug the vessel injury
• Has components necessary for limiting excessive formation of clots and those necessary for dissolving the clots over time
![Page 7: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/7.jpg)
Hemostasis
• Balance between procoagulants and down regulators
• Perturbation of this balance results in either bleeding or pathologic clot formation
– You either don’t clot when you need to or clot when you don’t need to
![Page 8: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/8.jpg)
Hemostasis
Coagulation Fibrinolysis
Bleeding Thrombosis
Thrombosis Bleeding
![Page 9: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/9.jpg)
Excessive Coagulation/Deficient Fibrinolysis
Coagulation
Fibrinolysis
Thrombosis
Thrombosis
![Page 10: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/10.jpg)
Excessive Fibrinolysis/Deficient Coagulation
Coagulation
Fibrinolysis
Bleeding
Bleeding
![Page 11: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/11.jpg)
Hemostatic Process: Five Steps
1. Vascular phase
2. Platelet phase
3. Coagulation phase
4. Clot retraction
5. Fibrinolysis
![Page 12: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/12.jpg)
Primary Hemostasis
• Process of forming a platelet plug at the sit of vessel injury
• Consists of vasoconstriction and platelet adhesion
![Page 13: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/13.jpg)
Vasoconstriction (Vascular phase)
• “Tightening” of blood vessels to divert blood flow around the damaged vessel
• Enhances contact activation of platelets and coagulation factors
![Page 14: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/14.jpg)
Platelet Adhesion (Platelet phase)
• Platelets become activated and aggregate at the site of injury, forming a temporary, loose, platelet plug
![Page 15: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/15.jpg)
Secondary Hemostasis
• To stabilize the initially loose platelet plug, a sequence of enzymatic reactions is initiated which culminates in fibrin strands forming at the platelet plug
• Fibrin mesh (clot) is formed and entraps the plug
![Page 16: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/16.jpg)
Coagulation phase
• Fibrin-forming system
• Coagulation factors interact with each other to form a fibrin clot
• Reinforces the platelet plug
![Page 17: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/17.jpg)
Coagulation Factors
• Proteins normally present in the blood
• Most are produced by the liver
• Normally “turned off” (inactive)
• Designated by roman numerals
• Common names are significant of patients’ last names who were deficient with the factor
• “a” signals the factor in its “active” form
![Page 18: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/18.jpg)
Coagulation Cascade
• Sequence of biochemical reactions that form an insoluble gel (clot)
• Converts fibrinogen to fibrin
• Domino or waterfall effect
• Each factor is converted into its active form by the preceding factor
![Page 19: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/19.jpg)
ENDOTHELIAL DAMAGEEndothelium secretes VWF which makes platelets stick to the injured
vessel and cause platelet aggregation
Endothelium secretes Tissue Factors that activate the Extrinsic system
EXTRINSIC SYSTEMINTRINSIC SYSTEM
Factor VIIXII CONTACT HMK
XIIaKAL
XI XIa
IX IXa
ENDOTHELIUM
Ca++
Plasminogen
Plasmin
Stable Fibrin Clot Fibrin Degradation Products
FibrinXIIIa
Thrombin
+ PF3 Factor VIIa
X Xa
V + Ca++ + PF3
Prothrombin
Fibrinogen
Factor XIIIActivated Protein C
Protein C
Protein S
Ca++Tissue Factor
VIIIVIII
Antithrombin III
![Page 20: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/20.jpg)
Extrinsic Pathway• Activated when endothelial cells are injured and tissue
factor is released
• Activated Factor VII and tissue factor bind to form a complex
– This complex, plus calcium, activates Factor X
Tissue Factor
VII VIIa
Ca+
X Xa
(Protrombin) II IIa (Thrombin)
Fibrinogen Fibrin
PF3 Ca++
![Page 21: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/21.jpg)
Intrinsic Pathway
• Requires clotting factors VIII-XII
• Initiation occurs when factor XII is exposed to a negatively charged surface– Termed the contact
phase• Exposure of collagen to a
vessel surface is the primary stimulus for the contact phase
Prekalikrein Kalikrein
XII XIIa
XI XIa
IX IXa
X Xa
PF3 Ca++
![Page 22: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/22.jpg)
Common Pathway• Activated by either extrinsic or intrinsic pathway
• When Factor Xa binds to the platelet surface, a complex is formed composed of platelet phospholipid, calcium and Factor Va
– Complex converts prothrombin to thrombin which in turn converts fibrinogen to fibrin
X Xa
(Prothrombin) Thrombin
Fibrinogen Fibrin
PF3Ca++
![Page 23: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/23.jpg)
Clot Generation
• Endothelial damage vWF platelets stick to endothelium (adhesion) exposure of collagen fibrils stimulates platelets to stick together (aggregation)
• Activation of coagulation
– Tissue factor on the surface of monocytes and endothelium activate various factors that lead to the formation of thrombin
![Page 24: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/24.jpg)
Clot Generation
• Thrombin changes properties of fibrinogenpolymerization fibrinmeshwork clot
• Fibrinolysis: dissolution of the fibrin clot
– Initiation of clot lysis begins concurrently with the activation of the clotting cascade
• Endothelium plasminogen plasmindegrades fibrin FDP
![Page 25: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/25.jpg)
Fibrinolysis• Body’s way of keeping coagulation from becoming
excessive and occluding the blood vessels
• Function of plasmin that circulates as the inactive proenzyme plasminogen
Fibrinogen
SolubleFibrin
Insoluble (stable)Fibrin Clot
FDPs Plasminogen
Plasmin
TissuePlasminogen
Activator
D
![Page 26: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/26.jpg)
Regulation
• Balance between coagulation and fibrinolytic processes must be maintained
– Otherwise, excess clotting or fibrinolysis will occur
• Body has inhibitors to regulate the system
Antithrombin
Protein C
Protein S
Plasmin Inhibitor
STOP
![Page 27: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/27.jpg)
ENDOTHELIAL DAMAGEEndothelium secretes VWF which makes platelets stick to the injured
vessel and cause platelet aggregation
Endothelium secretes Tissue Factors that activate the Extrinsic system
EXTRINSIC SYSTEMINTRINSIC SYSTEM
Factor VIIXII CONTACT HMK
XIIaKAL
XI XIa
IX IXa
ENDOTHELIUM
Ca++
Plasminogen
Plasmin
Stable Fibrin Clot Fibrin Degradation Products
FibrinXIIIa
Thrombin
+ PF3 Factor VIIa
X Xa
V + Ca++ + PF3
Prothrombin
Fibrinogen
Factor XIIIActivated Protein C
Protein C
Protein S
Ca++Tissue Factor
VIIIVIII
Antithrombin III
![Page 28: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/28.jpg)
Venous Thrombotic Event (VTE)
• Thrombophilia
– Hypercoagulable state due to inherited(hereditary/genetic) defects or acquired defects in one or several factors of the coagulation cascade
• Thrombophilia causes DVT (deep vein thrombosis) or PE (pulmonary embolism)
![Page 29: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/29.jpg)
Thrombotic Alert #1
• How many patients in the US are diagnosed with deep vein thrombosis each year?
More than 500,000
![Page 30: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/30.jpg)
Thrombotic Alert #2
• How many pulmonary embolisms are diagnosed each year in the US?
More than 630,000
![Page 31: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/31.jpg)
Thrombotic Alert #3
• How many deaths are attributed to PE each year?
Approximately 200,000 deaths
![Page 32: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/32.jpg)
Research Indicates…
• Approximately 100,000 of these deaths are preventable
• Half of pulmonary emboli are not diagnosed until…
AUTOPSY
![Page 33: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/33.jpg)
COAGULATION DISORDERS
![Page 34: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/34.jpg)
Hereditary/Genetic IrreversibleFactor I (Fibrinogen)
• Afibrinogenemia– Total absence of measurable fibrinogen
– Rare congenital disorder
• Hypofibrinogenemia– Below normal levels of fibrinogen
– Treated by cryoprecipitate or FFP
• Dysfibrinogenemia– Altered structure of the fibrinogen molecule
– Usually asymptomatic but has been associated with both bleeding and thrombotic events
![Page 35: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/35.jpg)
Factor V (Proaccelerin)
Gene Defect
• Cofactor in coagulation cascade
• Deficiency causes bleeding but…
– Factor V mutation (Factor V Leiden) causes thrombotic events due to impaired degradation of Factor V resulting in continued thrombin generation
• Most common cause of thrombophilia
![Page 36: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/36.jpg)
Defects in Prothrombin Gene
• Second most common cause of thrombophilia
• Prothrombin does not break down
– Keeps on activating thrombin to convert fibrinogen into a fibrin clot
![Page 37: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/37.jpg)
Defects of Methyl Tetrahydrofolate Reductase (MTHFR) Enzyme
• MTHFR breaks down homocysteine
• Deficiency of MTHFR increases homocysteine, leading to thrombosis
• Acquired homocysteinemia is due to deficiency of folate, vitamins B6 and B12
![Page 38: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/38.jpg)
Less Common
• Antithrombin III deficiency
• Protein C deficiency
• Protein S deficiency
![Page 39: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/39.jpg)
Factor VIII (Antihemophilic Factor)
• Composed of a coagulant portion and vWF (vonWillebrand Factor)
• Acute phase reactant– Increase in inflammation, stress, pregnancy and
infection which can lead to clot formation
• Defect or absence of coagulant portion causes classic Hemophilia A
• Deficiency in vWF portion causes vonWillebrand’s Disease
![Page 40: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/40.jpg)
Acquired/Environmental Risk Factors for VTE
• Extended bed rest
• Malignancy (cancer)
• Oral contraceptives (estrogen)
• Hormonal replacement therapy
• Pregnancy and recent surgery
• Trauma
• Obesity/inactivity
• Antiphospholipid antibodies (APA)
• Anticardiolipin Antibodies (ACA)
• Lupus Anticoagulants(LA)
• Inflammatory bowel disease (IBD)
![Page 41: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/41.jpg)
Most Commonly Requested Coagulation Tests
• Prothrombin Time (PT)
• Activated Partial Thromboplastin Time (aPTT/PTT)
• Fibrinogen Assay
• Factor Assays
• D-Dimer
• FDP
• Bleeding Time
![Page 42: Anticoagulation theory 2_students_](https://reader034.vdocuments.us/reader034/viewer/2022042614/556da2e6d8b42a875d8b4779/html5/thumbnails/42.jpg)
Pathways/Tests
• PT monitors extrinsic pathway
– PT monitors coumadin therapy
• aPTT/PTT monitors intrinsic pathway
– aPTT/PTT monitors heparin therapy
• PT and aPTT/PTT both monitor the common pathway